Thalidomide for dermatology: a review of clinical uses and adverse effects.
Faver
Inacio R
IR
Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA.
Guerra
Samantha G
SG
Su
W P Daniel
WP
el-Azhary
Rokea
R
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy*; D013723:Teratogens; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D013723:Teratogens; D013792:Thalidomide